The journey from discovery to commercial manufacturing demands expression technologies that deliver speed, performance, and confidence at every stage. Lonza's GS Gene Expression System® platform powers the development of biotherapeutic proteins with a comprehensive toolbox of proven technologies, expert support, and continuous innovation. Featuring the latest GS Ori-Go® vectors, the platform supports higher titers, streamlined workflows, and accelerated timelines, helping you reach stable cell lines faster while reducing development risk. Backed by more than 30 years of experience, a track record supporting 100+ commercial products, the GS Gene Expression System® helps you advance diverse molecule types from discovery to commercial success.
You may also be interested in:
View our technical brief
Latest briefing from the Knowledge Center